We are live on ! Find out more
OMGA

Omega Therapeutics, Inc. Common Stock
OMGA

Delisted

OMGA was delisted on the 24th of February, 2025.

Back to rankings

54 hedge funds and large institutions have $303M invested in Omega Therapeutics, Inc. Common Stock in 2023 Q1 according to their latest regulatory filings, with 10 funds opening new positions, 27 increasing their positions, 6 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

350% more repeat investments, than reductions

Existing positions increased: 27 | Existing positions reduced: 6

100% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 5

33% more call options, than puts

Call options by funds: $338K | Put options by funds: $255K

10% more funds holding

Funds holding: 49 → 54 (+5)

22% less capital invested

Capital invested by funds: $389M → $303M (-$86.2M)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

Holders
54
Holders Change
+5
Holders Change %
+10.2%
% of All Funds
0.86%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
10
Increased
27
Reduced
6
Closed
5
Calls
$338K
Puts
$255K
Net Calls
+$83K
Net Calls Change
+$112K

Top Buyers

Rank Fund Capital Flow
1
FP
Flagship Pioneering
Massachusetts
+$23.1M
2
HP
Harbourvest Partners
Massachusetts
+$6.02M
3
Fidelity Investments
Fidelity Investments
Massachusetts
+$5.7M
4
6CM
683 Capital Management
New York
+$3.5M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$2.95M

Top Sellers

Rank Fund Capital Flow
1
OMC
Oasis Management Company
Cayman Islands
-$914K
2
BlackRock
BlackRock
New York
-$186K
3
Man Group
Man Group
United Kingdom
-$114K
4
Citadel Advisors
Citadel Advisors
Florida
-$104K
5
Simplex Trading
Simplex Trading
Illinois
-$76K
Name Holding Trade Value Shares
Change 		Change in
Stake
FP
1
Flagship Pioneering
Massachusetts
$176M +$23.1M +3,323,310 +13%
Fidelity Investments
2
Fidelity Investments
Massachusetts
$32.7M +$5.7M +818,216 +18%
HP
3
Harbourvest Partners
Massachusetts
$21.2M +$6.02M +865,051 +33%
AG
4
Artal Group
Luxembourg
$15.3M +$1.81M +259,515 +11%
State of Wisconsin Investment Board
5
State of Wisconsin Investment Board
Wisconsin
$11.2M – – –
Vanguard Group
6
Vanguard Group
Pennsylvania
$8.44M +$2.95M +423,300 +43%
CA
7
CHI Advisors
New York
$6.37M – – –
PIM
8
Platinum Investment Management
Australia
$5.57M +$2.36M +339,553 +58%
LCM
9
Laurion Capital Management
New York
$3.44M +$964K +138,408 +32%
BlackRock
10
BlackRock
New York
$3.3M -$186K -26,763 -5%
6CM
11
683 Capital Management
New York
$3.2M +$3.5M +503,009 +1,842%
7IH
12
72 Investment Holdings
Connecticut
$2.13M – – –
OIM
13
Oracle Investment Management
Connecticut
$2.01M +$2.32M +333,836 New
SOMRS
14
State of Michigan Retirement System
Michigan
$1.89M – – –
Millennium Management
15
Millennium Management
New York
$1.29M +$1.23M +176,787 +478%
Susquehanna International Group
16
Susquehanna International Group
Pennsylvania
$1.17M +$486K +69,772 +56%
Geode Capital Management
17
Geode Capital Management
Massachusetts
$1.09M – – –
KCM
18
Knoll Capital Management
Florida
$1.04M +$1.2M +173,010 New
Point72 Asset Management
19
Point72 Asset Management
Connecticut
$791K +$12.5K +1,800 +1%
Jane Street
20
Jane Street
New York
$556K +$642K +92,145 New
Morgan Stanley
21
Morgan Stanley
New York
$435K +$286K +41,069 +132%
RC
22
RBF Capital
California
$422K -$50.9K -7,307 -9%
Citigroup
23
Citigroup
New York
$341K +$160K +22,950 +68%
State Street
24
State Street
Massachusetts
$336K +$29.2K +4,200 +8%
Goldman Sachs
25
Goldman Sachs
New York
$309K +$242K +34,816 +211%
1
2 3

OMGA Hedge Fund Activity: Q1 2023 in Review

54 of the 6,276 institutional investors tracked by Wall St. Rank reported a position in Omega Therapeutics, Inc. Common Stock (OMGA) for Q1 2023, worth a combined $303M — down 22% from $389M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new OMGA positions and 5 closed out — a net gain of 5 holders — while 27 added to existing stakes and 6 trimmed.

The largest buyer was Flagship Pioneering, adding an estimated $23.1M. The largest seller was Oasis Management Company, exiting entirely with an estimated $914K sold.

  • 54 institutional investors held Omega Therapeutics, Inc. Common Stock (OMGA) as of Q1 2023, up from 49 in Q4 2022.
  • Funds reported $303M of Omega Therapeutics, Inc. Common Stock stock for Q1 2023, down 22% quarter-over-quarter.
  • 10 funds opened new Omega Therapeutics, Inc. Common Stock positions in Q1 2023 and 5 closed out, a net change of +5 holders.
  • The largest Omega Therapeutics, Inc. Common Stock buyer in Q1 2023 was Flagship Pioneering, an estimated $23.1M added.
  • The largest Omega Therapeutics, Inc. Common Stock seller in Q1 2023 was Oasis Management Company, an estimated $914K sold.

Based on aggregated 13F filings for Q1 2023.